Transcenta Holding Limited
Research Transcenta Holding Limited (6628.HK) on Bullrun: market cap HKD 277.52M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6628.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyHKD
- Market capHKD 277.52M
- Financial periodFY2025
- RevenueCNY 7.44M
- Revenue growth-34.0%
- Net income-CNY 203.73M
- Free cash flow-CNY 142.97M
- Gross margin23.1%
Valuation Snapshot
latest market cap is HKD 277.52M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 7.44M | -CNY 203.73M | -CNY 142.97M | 23.1% | n/a | CNY 14.14M | CNY 126.26M | CNY 618.09M |
| FY2024 | CNY 11.26M | -CNY 290.29M | -CNY 216.15M | 35.5% | -0.72 | CNY 169.42M | CNY 250.61M | CNY 751.64M |
| FY2023 | CNY 53.85M | -CNY 462.57M | -CNY 373.80M | 26.7% | -1.14 | CNY 546.03M | CNY 409.63M | CNY 1.03B |
| FY2022 | CNY 101.89M | -CNY 406.75M | -CNY 318.03M | 19.5% | -0.94 | CNY 895.45M | CNY 411.46M | CNY 1.47B |
| FY2021 | n/a | n/a | n/a | n/a | -9.34 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 277.52M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Transcenta Holding Limited
Transcenta Holding Limited, a clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People's Republic of China and the United States. The company develops TST001, a humanized claudin 18.2 mAb candidate for solid tumors, such as gastric and gastroesophageal cancer; TST808, a humanized antibody neutralizing APRIL targeting B/plasma cell;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Transcenta Holding Limited's market cap?
Transcenta Holding Limited's market capitalization is HKD 277.52M.
What does Transcenta Holding Limited do?
Transcenta Holding Limited, a clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People's Republic of China and the United States.